Also interesting

GSK continues to invest heavily in Belgium at its sites in Wavre and Rixensart
The British pharmaceutical company GSK continues to invest in its production site in Wavre and its research and development site in Rixensart...

GMP certification for Exothera further extends its viral vector manufacturing capacity
Exothera achieves GMP certification and extends its facilities by a further 2,100 m² (22,600 ft²) production bringing the total capacity to 8,600 m² (92,570 ft²) for viral vector development and manufacturing...

Takeda Lessines saves 600 million litres of water per year
In March 2021, the pharmaceutical company Takeda inaugurated a new wastewater recycling facility in Lessines...